A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain

Clinical trial NCT05359133 · TERMINATED

Trial details

NCT number: NCT05359133
Sponsor: Wex Pharmaceuticals Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-induced Neuropathic Pain Chemotherapy-induced Peripheral Neuropathy

Start date: 2022-04-19
Primary completion: 2024-10-14
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.